These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 11719431)

  • 1. LYVE-1 is not restricted to the lymph vessels: expression in normal liver blood sinusoids and down-regulation in human liver cancer and cirrhosis.
    Mouta Carreira C; Nasser SM; di Tomaso E; Padera TP; Boucher Y; Tomarev SI; Jain RK
    Cancer Res; 2001 Nov; 61(22):8079-84. PubMed ID: 11719431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular endothelial growth factor-D induces lymphangiogenesis and lymphatic metastasis in models of ductal pancreatic cancer.
    Von Marschall Z; Scholz A; Stacker SA; Achen MG; Jackson DG; Alves F; Schirner M; Haberey M; Thierauch KH; Wiedenmann B; Rosewicz S
    Int J Oncol; 2005 Sep; 27(3):669-79. PubMed ID: 16077915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor lymphangiogenesis in inflammatory breast carcinoma: a histomorphometric study.
    Van der Auwera I; Van den Eynden GG; Colpaert CG; Van Laere SJ; van Dam P; Van Marck EA; Dirix LY; Vermeulen PB
    Clin Cancer Res; 2005 Nov; 11(21):7637-42. PubMed ID: 16278382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the hyaluronan receptor LYVE-1 is not restricted to the lymphatic vasculature; LYVE-1 is also expressed on embryonic blood vessels.
    Gordon EJ; Gale NW; Harvey NL
    Dev Dyn; 2008 Jul; 237(7):1901-9. PubMed ID: 18570254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular phenotypes and spatio-temporal patterns of lymphatic vessel development in embryonic mouse hearts.
    Flaht A; Jankowska-Steifer E; Radomska DM; Madej M; Gula G; Kujawa M; Ratajska A
    Dev Dyn; 2012 Sep; 241(9):1473-86. PubMed ID: 22753134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of interleukin-7 on the lymphangiogenic properties of human endothelial cells.
    Al-Rawi MA; Watkins G; Mansel RE; Jiang WG
    Int J Oncol; 2005 Sep; 27(3):721-30. PubMed ID: 16077922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphatic vessels in vascularized human corneas: immunohistochemical investigation using LYVE-1 and podoplanin.
    Cursiefen C; Schlötzer-Schrehardt U; Küchle M; Sorokin L; Breiteneder-Geleff S; Alitalo K; Jackson D
    Invest Ophthalmol Vis Sci; 2002 Jul; 43(7):2127-35. PubMed ID: 12091407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymph and blood vessel architecture in benign and malignant prostatic tissue: lack of lymphangiogenesis in prostate carcinoma assessed with novel lymphatic marker lymphatic vessel endothelial hyaluronan receptor (LYVE-1).
    Trojan L; Michel MS; Rensch F; Jackson DG; Alken P; Grobholz R
    J Urol; 2004 Jul; 172(1):103-7. PubMed ID: 15201747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphatic endothelium-specific hyaluronan receptor LYVE-1 is expressed by stabilin-1+, F4/80+, CD11b+ macrophages in malignant tumours and wound healing tissue in vivo and in bone marrow cultures in vitro: implications for the assessment of lymphangiogenesis.
    Schledzewski K; Falkowski M; Moldenhauer G; Metharom P; Kzhyshkowska J; Ganss R; Demory A; Falkowska-Hansen B; Kurzen H; Ugurel S; Geginat G; Arnold B; Goerdt S
    J Pathol; 2006 May; 209(1):67-77. PubMed ID: 16482496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Selective deposition of agrin in the microvasculature of hepatocellular carcinoma: aspects in pathogenesis and differential diagnosis].
    Tátrai P
    Magy Onkol; 2008 Dec; 52(4):379-83. PubMed ID: 19068466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High LYVE-1-positive lymphatic vessel numbers are associated with poor outcome in breast cancer.
    Bono P; Wasenius VM; Heikkilä P; Lundin J; Jackson DG; Joensuu H
    Clin Cancer Res; 2004 Nov; 10(21):7144-9. PubMed ID: 15534085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of lymphatic vessels in mouse thymus: immunofluorescence analysis.
    Odaka C; Morisada T; Oike Y; Suda T
    Cell Tissue Res; 2006 Jul; 325(1):13-22. PubMed ID: 16541287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First year changes of myocardial lymphatic endothelial markers in heart transplant recipients.
    Geissler HJ; Dashkevich A; Fischer UM; Fries JW; Kuhn-Régnier F; Addicks K; Mehlhorn U; Bloch W
    Eur J Cardiothorac Surg; 2006 May; 29(5):767-71. PubMed ID: 16439147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of lymphangiogenesis and lymphangiogenic factors during pancreatic cancer progression and lymphatic spread.
    Schneider M; Büchler P; Giese N; Giese T; Wilting J; Büchler MW; Friess H
    Int J Oncol; 2006 Apr; 28(4):883-90. PubMed ID: 16525637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumour expression of lymphangiogenic growth factors but not lymphatic vessel density is implicated in human cervical cancer progression.
    Sotiropoulou N; Bravou V; Kounelis S; Damaskou V; Papaspirou E; Papadaki H
    Pathology; 2010 Dec; 42(7):629-36. PubMed ID: 21080871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of platelet-derived growth factor receptor alpha in endothelial cells of hepatocellular carcinoma associated with high metastatic potential.
    Zhang T; Sun HC; Xu Y; Zhang KZ; Wang L; Qin LX; Wu WZ; Liu YK; Ye SL; Tang ZY
    Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8557-63. PubMed ID: 16361537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LYVE-1 expression on high endothelial venules (HEVs) of lymph nodes.
    Wróbel T; Dziegiel P; Mazur G; Zabel M; Kuliczkowski K; Szuba A
    Lymphology; 2005 Sep; 38(3):107-10. PubMed ID: 16353487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The potential lymphangiogenic effects of hepatocyte growth factor/scatter factor in vitro and in vivo.
    Jiang WG; Davies G; Martin TA; Parr C; Watkins G; Mansel RE; Mason MD
    Int J Mol Med; 2005 Oct; 16(4):723-8. PubMed ID: 16142411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absence of lymphangiogenesis and intratumoural lymph vessels in human metastatic breast cancer.
    Williams CS; Leek RD; Robson AM; Banerji S; Prevo R; Harris AL; Jackson DG
    J Pathol; 2003 Jun; 200(2):195-206. PubMed ID: 12754740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular and cellular mechanisms of lymphangiogenesis.
    Al-Rawi MA; Mansel RE; Jiang WG
    Eur J Surg Oncol; 2005 Mar; 31(2):117-21. PubMed ID: 15698725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.